Company profile

Xuanzhu Biopharmaceutical

2575 · HKEX

Public Market Listing

2575HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Xuanzhu Biopharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
XZP-3287
Phase 3
CDK4/6Small molecule
HR+/HER2- Breast Cancer
HR+/HER2- Metastatic Breast Cancer
XZP-3621
Phase 3
ALK / ROS1Small molecule
Non-Small Cell Lung Cancer
XZP-5955
Phase 2
ROS1/NTRKSmall molecule
Non-Small Cell Lung Cancer
XZB-0004
Phase 1
AXLSmall molecule
Non-Small Cell Lung Cancer

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.